BioStem Technologies, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of BSEM for the last quarter is 74.49 M USD, and it's 77.77% higher compared to the previous quarter. The net income of Q2 24 is 6.29 M USD.